• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall BC Hammock Mesh Sling

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards | Inspections
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Recall
BC Hammock Mesh Sling
see related information
Date Posted June 19, 2013
Recall Status1 Terminated on November 25, 2013
Recall Number Z-1555-2013
Recall Event ID 65263
Product Classification Lift, Patient, Non-Ac-Powered - Product Code FSA
Product BC Hammock Mesh Sling (Junior), product number, 537005. Product Usage: The fabric sling is used for the transfer of a patient, for example from a bed to a wheelchair.
Code Information Lot: PHM000524.
Recalling Firm/
Manufacturer
Prism Medical Services USA
45 Progress Pkwy
Maryland Heights, Missouri 63043-3701
For Additional Information Contact Agustin Garcia de Paredes, P.Eng
905-850-9003 Ext. 249
Manufacturer Reason
for Recall
The product does not meet the firm's size standards, the product was produced in the incorrect size.
FDA Determined
Cause 2
TRAINING: Employee Error
Action Prism Medical contacted their US consignees on May 28, 2013 with an e-mail notification of the recall. The notification explained the Field Safety Notice Letter dated May 22, 2013. The notice identified the affected product, problem and actions to be taken. Customers were instructed to contact Customer Service at Prism Medical to receive a return goods authorization to replace the affected product at no charge. For questions call 905-850-9003 Ext. 249.
Quantity in Commerce 1 sling
Distribution Worldwide distribution: USA (nationwide) including states of: CA, IL, OH, and TX. and country of: Canada.
Total Product Life Cycle TPLC Device Report

 
1 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
-
-